ImportRefusal LogoImportRefusal

Mundo Express

⚠️ High Risk

FEI: 3012161820 • Morelia, Michoacan de Ocampo • MEXICO

FEI

FEI Number

3012161820

📍

Location

Morelia, Michoacan de Ocampo

🇲🇽

Country

MEXICO
🏢

Address

Calle 20 de Noviembre 506, Unidad Habitacional Centro Historico, Morelia, Michoacan de Ocampo, Mexico

High Risk

FDA Import Risk Assessment

60.3
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

20
Total Refusals
3
Unique Violations
9/7/2022
Latest Refusal
11/5/2018
Earliest Refusal

Score Breakdown

Violation Severity
84.8×40%
Refusal Volume
49.0×30%
Recency
32.7×20%
Frequency
52.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7519×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

3241×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

4821×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

Refusal History

DateProductViolationsDivision
9/7/2022
54YEY99VITAMIN, MINERAL, PROTEINS AND UNCONVENTIONAL DIETARY SPECIALITIES FOR HUMANS AND ANIMALS, N.E.C.
324NO ENGLISH
482NUTRIT LBL
Division of Southeast Imports (DSEI)
7/26/2021
60LCA69TRAMADOL HCL (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2021
60LCA69TRAMADOL HCL (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2021
60LCY69TRAMADOL HCL (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2021
62GCY46KETOPROFEN (ANTI-INFLAMMATORY)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2021
64LCY03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2021
61KCA11BIPERIDEN HCL (ANTI-CHOLINERGIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2021
61PCY99ANTI-DIABETIC N.E.C.
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/26/2021
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
6/24/2021
61MCA06CLONAZEPAM (ANTI-CONVULSANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/17/2021
61MCA06CLONAZEPAM (ANTI-CONVULSANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)
5/18/2020
61TCA31DOMPERIDONE
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/30/2019
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/30/2019
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/30/2019
66SCY51TADALAFIL
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/29/2018
62KCY10OMEPRAZOLE (ANTI-PERISTALTIC, ANTI-DIARRHEAL)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/29/2018
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/29/2018
66VDA99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/16/2018
60NCA20DEHYDROEPIANDROSTERONE (ANDROGEN)
75UNAPPROVED
Division of Southeast Imports (DSEI)
11/5/2018
66VCY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is Mundo Express's FDA import refusal history?

Mundo Express (FEI: 3012161820) has 20 FDA import refusal record(s) in our database, spanning from 11/5/2018 to 9/7/2022.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Mundo Express's FEI number is 3012161820.

What types of violations has Mundo Express received?

Mundo Express has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Mundo Express come from?

All FDA import refusal data for Mundo Express is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.